The Institute of Cancer Research’s Post

We’ve got a number of colleagues taking part in the Royal Parks Half Marathon this Sunday🎉 🎽 🏃   Check out what they do at the ICR and find out how you can support them ⤵️   Simon Francis, our Director of Estates and Facilities, has lost family and friends to cancer and, having seen how important our research is, he decided to help raise funds to continue our mission to make more discoveries to defeat cancer. https://lnkd.in/evhB8qHF   Shaun Tan is an analytical scientist working in breast cancer research at the ICR. He’s running a half marathon for the first time. Shaun wanted to contribute even more to our research because he knows first-hand how much effort from scientists and funding support is needed to make progress to defeat cancer. https://lnkd.in/eamNevpD   Dr Sam Lawrence is an ICR researcher working on the genetics of cancer. He’s fundraising for the ICR because he knows how important our research is in discovering and developing more personalised cancer treatments that are both more effective and kinder for patients. https://lnkd.in/e_YCYQJZ   Professor Kevin Harrington is Head of the Division of Radiotherapy and Imaging at the ICR. Kevin’s incredibly grateful for the support he gets from CRIS Cancer Foundation for his research – and as a clinician scientist for the last three decades, he’s seen the impact research has had on improving and saving lives. https://lnkd.in/eEvkW7Dx Good to everyone taking part, we're with you all the way 💙 #TheInstituteofCancerResearch #ICR #CancerResearch #DrugDiscovery #RoyalParksHalfMarathon #RoyalParks #Marathon #Fundraising #Research #DefeatCancer #Science

"When I first joined the ICR, it was really nice. I felt very welcomed" 🎉 To celebrate Hispanic and Latin American Heritage Month, Érica Oliveira, Senior Scientific Officer in the Molecular Pathology Department share what this month means to her and how she stays connected to her community and culture whilst living in the UK "Hispanic and Latin Heritage Month means remembering my background, my history and where I came from" "To remember my community, I do have friends from Brazil and we get together to eat traditional food, it's also nice to speak in my own language sometimes" #TheInstituteofCancerResearch #ICR #cancerresearch #drugdiscovery #HispanicHeritageMonth2024 #hispanicandlatinheritagemonth #HispanicHeritageMonth #WomenInSTEM #WomenInScience

NEWS 📰: Personalised radiotherapy could offer a kinder way of treating #BladderCancer. Adapting treatment based on the size and position of the bladder was found to be safe in the Phase II RAIDER trial, which could improve patients' quality of life ⤵️ https://lnkd.in/en5z5D-r #TheInstituteofCancerResearch #ICR #CancerResearch #Radiotherapy

Happy Ada Lovelace Day! 🖥️ #AdaLovelace is known for being the first computer programmer and paved the way for #WomenInSTEM. Dr Jessica May Hislop, a Bioinformatician in our Genetics and Epidemiology Division is one of our many inspiring women breaking boundaries in #STEM.💙 #TheInstituteofCancerResearch #ICR #CancerResearch #Bioinformatician #ALD24 #AdaLovelaceDay #AdaLovelaceDay2024 #AdaLovelaceDay24 #ComputerScience Ada Lovelace Day

We are delighted to be part of a new multimillion-pound research project – involving 16 institutions and 11 industry partners - aiming to discover why at least half of patients fail to respond to #Immunotherapy treatments. The MANIFEST programme is funded by £9m from the Medical Research Council and the Office for Life Sciences, and £12.9m in matched funds from industry partners. It will involve thousands of patients treated with immunotherapy across the UK. Professor Manuel Salto-Tellez, Professor of Integrative Pathology at the ICR, who is one of the co-leads of MANIFEST, said: “Immunotherapies have transformed treatment for some patients but there is still a long way to go. We need more complex biomarkers to beat a complex disease like cancer. MANIFEST aims to identify new, better biomarkers to predict the response to immunotherapies.” Read more here ⤵️ https://lnkd.in/epxbvkCa #TheInstituteofCancerResearch #ICR #CancerResearch #Research UK Research and Innovation Department for Science, Innovation and Technology #Cancer #CancerTreatment #Biomarkers

REMINDER 🔔 Sign up for our free online #PhD application workshop to learn more about the process and what is involved, receive guidance and advice from our academic recruitment lead and hear from current PhD students about their journey! 📅 Monday 7 October 🕐 13:00 - 14:00 (UK time) https://lnkd.in/eU-Fp6Sc #TheInstituteofCancerResearch #CancerResearch #ICR

📢 Interested in doing a #PhD at ICR? Join our free online workshop to hear from our academic recruitment lead about the application process and will provide guidance and advice, hear from current PhD students who will share their experiences and you'll have the opportunity to ask any questions about the process. 📅 Monday 7 October 🕐 13:00 -14:00 (UK time) Don't delay, sign up ⤵️ https://lnkd.in/eU-Fp6Sc #TheInstiuteofCancerResearch #CancerResearch #Cancer #DrugDiscovery #PhDRecruitment

“Becoming a cancer patient has given me extra perspective” Professor Paul Workman has worked in the field of cancer research for more than 50 years and was the ICR’s Chief Executive and President from 2014 to 2021. During his leadership, he oversaw many of our scientific successes – including the development of smarter and kinder forms of radiotherapy. Something he would later benefit from himself… Having lost his father to bowel cancer and his mother to a rare bone cancer, Paul was diagnosed with prostate cancer in 2022. But now with his treatment behind him, he can reflect on his experience, both as a leading cancer scientist and now a cancer patient. Read Paul’s full story ⤵️ https://lnkd.in/e_v-4zvK

An ICR team led by Clare Turnbull has developed a new clinical pathway that will speed up #BRCA testing and ensure #BreastCancer patients get the treatment they need. Read more here ⤵️ https://lnkd.in/eZRrA8MP #TheInstituteofCancerResearch #ICR #CancerResearch #DrugDiscovery

“ICR has made significant efforts over the years that I’ve been working here to put diversity as one of the major pillars of our culture.” It's Hispanic and Latin American Heritage Month 🎉 To mark the occasion, Luis Zapata, Team Leader in the Evolutionary Immunogenomics department shares why this month is important to him and his experience of working at the ICR. "Hispanic and Latin Heritage Month means a lot to me and lot to people who have travelled from overseas to work in the UK" "For scientists in particular, it's very important, all the cultural diversity and understand that people come from different places" #TheInstituteofCancerResearch #ICR #cancerresearch #drugdiscovery #HispanicHeritageMonth2024 #hispanicandlatinheritagemonth #HispanicHeritageMonth